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In South Africa (SA), as is the case globally, obstetric haemorrhage 
(OH) remains a leading contributor to maternal mortality and 
morbidity despite being the focus of related research and health 
interventions.[1-3] Delayed recognition of risk factors for OH and 
failure to provide effective peripartum care directly and adversely 
affect maternal outcomes. This is most notable in resource-poor 
settings, particularly where rural geography, ineffective referral and 
transportation systems compound risk associated with obstetric 
emergencies.[4,5] Consequently, OH and high rates of blood trans-
fusion prescribed for OH are frequently encountered in resource-
poor settings, which is evident in SA.[6,7] 
A shortfall in the provision of blood transfusion is estimated to 
contri bute to a quarter of maternal deaths in sub-Saharan Africa.[8] 
Specific to SA, postpartum haemorrhage continued to contribute signifi-
cantly to maternal deaths over the last reported triennium (2011 
- 2013).[3] While data are available for OH and maternal mortality, 
those pertaining to blood use in this population are lacking. For 
example, despite availability of published transfusion guidelines in 
SA in the obstetric setting, compliance with these guidelines is largely 
unknown.[9] Obstetric blood transfusion places a significant burden 
on local blood transfusion services in SA, whereby improved data 
are necessary for planning. More specifically, an understanding of 
risk factors for peripartum transfusion can identify deficiencies of 
care, thus informing rational intervention. Finally, ~30% of pregnant 
women in SA are HIV-positive;[10] in these patients associated antenatal 
anaemia may place them at risk of peripartum blood transfusion. 
Despite strained transfusion inventories in SA, a previous study 
demonstrated high rates of blood transfusion compared with 
high-resource settings, even though there were comparable rates 
of OH.[11] We investigated the risk factors underlying peripartum 
transfusion in semi-rural SA, thereby complementing the earlier 
study that had been conducted in urban SA hospitals.[11] We also 
gathered contemporary data on the proportion of the obstetric 
population that is HIV-positive as well as antiretroviral treatment 
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Background. Obstetric haemorrhage (OH) remains a major contributor to maternal morbidity and mortality. Blood transfusion is critical 
in OH management; yet, data on peripartum transfusion are lacking. A pilot study reported high rates of peripartum transfusion in a sample 
of South African (SA) hospitals, which was independently associated with HIV status.
Objectives. To assess the incidence of peripartum transfusion in a sample of Eastern Cape, SA hospitals to evaluate generalisability of 
preceding study findings. 
Methods. Hospital chart reviews were conducted of all deliveries at three large regional hospitals from February to June 2013. Additional 
clinical data were collected for patients who sustained OH and/or were transfused. 
Results. A total of 7 234 women were enrolled in the study; 1 988 (27.5%) were HIV-positive. Of the 767 HIV-positive women with a CD4 
count <350 cells/µL, 86.0% were on full antiretroviral therapy and 9.9% received drugs for prevention of mother-to-child transmission. The 
overall transfusion rate was 3.2%, with significant variability by hospital: Frere Hospital (1.5%), Dora Nginza Hospital (3.8%) and Cecilia 
Makiwane Hospital (4.6%). The number of red blood cell units per transfused patient and per delivery varied significantly by hospital. 
Bivariate analysis showed significant association between transfusion and HIV status. In a multivariate analysis, controlling for OH, age, 
mode of delivery, gestational age, parity and birthweight, this association (odds ratio 1.45; 95% confidence interval 0.78 - 2.71) was no 
longer significant.
Conclusion. These findings confirm high rates of peripartum transfusion in SA. While this can be possibly ascribed to variability in practice 
and patient profile, variation in care and improvement in HIV treatment should be considered.
S Afr Med J 2016;106(11):1103-1109. DOI:10.7196/SAMJ.2016.v106i11.10870
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regimens in use to evaluate the level of compliance with standard 
guidelines. 
Methods
Study design and subjects
We conducted a cross-sectional, hospital chart review of all deliver-
ies at three large regional hospitals in the Eastern Cape, SA: Dora 
Nginza Hospital (DNH) in Port Elizabeth, Frere Hospital (FH) in 
East London, and Cecilia Makiwane Hospital (CMH) in Mdantsane. 
The study was conducted over 4.5 months (February - June 2013). 
Ethical approval was obtained from the University of California, San 
Francisco (UCSF), USA, the SA National Blood Service (SANBS), 
Johannesburg, the Eastern Cape Department of Health, East London, 
and RTI International, Rockville, USA. The study was performed 
under an approved waiver of consent for the collection of retrospec-
tive data without personal identifiers. 
All three hospitals are part of the public sector healthcare system 
in SA, which provides medical services to low-income and uninsured, 
predominantly black (African) and coloured (mixed population 
group) patients. Each of the hospitals provides a broad range of 
routine obstetric services, and also serves as a referral centre for the 
surrounding district hospitals and midwife obstetric units. 
The study adopted a similar approach to that used by the Recipient 
Epidemiology and Donor Evaluation Study-III (REDS-III) Obstetric 
Hemorrhage Pilot Study.[11] Limited data were collected for all 
peripartum obstetric patients who had an index hospitalisation at 
a participating hospital. Comprehensive data were collected for the 
subset of patients who sustained OH and/or were transfused. Eligible 
patients were identified through daily review of the admission 
registers for the various wards and theatres, coupled with direct 
communication with the local blood bank and ward staff. The data 
were collected using the Obstetric Hemorrhage Audit Tool (OHAT), 
which was adapted from the instrument used in the previous 
study.[11] Volume of blood loss was not routinely recorded at CMH 
and FH. The data were subsequently transferred to RTI International, 
the data co-ordinating centre, for quality control and analysis.
Definitions
We used the same definitions as those used in the previous study.[11] 
OH was defined as any obstetric-related haemorrhage occurring in the 
peripartum period, the latter defined as 48 hours prior, during or post 
delivery. In accordance with the World Health Organization (WHO)’s 
definition, peripartum haemorrhage refers to blood loss ≥500 mL for 
vaginal deliveries or ≥1 000 mL for caesarean sections. All women 
who delivered at at least 26 weeks’ gestation were included in the 
study, independent of stillbirths or early neonatal deaths (pregnancy-
related haemorrhage prior to 26 weeks gestation is typi cally managed 
by gynaecology departments in SA). Transfusion was defined as 
having received a transfusion of any allogeneic blood product, e.g. red 
blood cells (RBCs), platelets, plasma and/or cryoprecipitate; however, 
only RBC transfusions were used for calculating transfusion parame-
ters. Booked refers to patients who had access to antenatal care, while 
unbooked refers to those who had not accessed any antenatal care 
during the index pregnancy. The most recently measured haemo-
globin prior to the delivery admission was recorded as the antenatal 
haemoglobin. Similarly, the pre- and post-haemoglobin values refer 
to the last haemoglobin level prior to and the first haemoglobin level 
after the transfusion, respectively. The δ-haemoglobin is the differ-
ence between the post- and pre-haemoglobin levels and is used to 
calculate the haemoglobin increment per transfused RBC unit. 
HIV status and HIV-related medication regimens were recorded. 
Prevention of mother-to-child transmission (PMTCT) refers to 
the use of limited antiretroviral monotherapy during the antenatal 
period, followed by additional antiretroviral treatment (ART) peri-
partum, administered specifically to mitigate against vertical HIV 
transmission. ART refers to the use of triple-therapy antiretroviral drugs.
Statistical analysis
Standard summary statistics were used to generate counts and 
percentages for categorical data and distributions for continuous 
variables. For categorical data, counts and percentages for single 
variables and combinations of variables were produced using χ2 tests 
of significance. For the continuous data, distributions were examined 
individually and stratified by covariates, using t-tests to establish 
differences between means.
Mutlivariate modelling was limited to data from DNH and was 
conducted using logistic regression. A larger set of variables was 
initially considered. The model was refined using backwards elimina-
tion at the p=0.05 level to retain variables. Once a set of variables was 
identified, interactions were investigated. The models were subjected 
to the Hosmer-Lemeshow test for goodness of fit. SAS 9.3 (TS1M2) 
(SAS Institute Inc., USA) with enhanced analytical product SAS/
STAT 12.1 (SAS Institute Inc., USA) was used for the data manipula-
tion and analysis; R version 3.0.1 – Good Sport (R Core Team, USA) 
was used for the data visualisation.
Results
A total of 7 234 women were enrolled in the study (Table 1). The major-
ity of the participants were aged 19 - 29 years and 9.3% were ≤18 years. 
The racial distribution was predominantly black and coloured. The 
women were mostly gravida 1 or 2 and para 0 or 1. More than 95% of 
the women had received antenatal care. The majority of births were 
normal vaginal deliveries, but there were high rates of caesarean sec-
tion; 1.7% of births occurred before arrival at the hospital. Overall, 
27.5% of the patients were HIV-positive and prevalence varied 
slightly by site. 
A total of 234 (3.2%) women were transfused. Bivariate analysis 
demonstrated significant variability in transfusion incidence by 
hospital: FH (1.5%), DNH (3.8%) and CMH (4.6%) (p<0.00001) 
(Table 2). Significantly increased transfusion rates were noted with 
increased parity; also among unbooked patients (7.1%) compared 
with booked patients (3.0%). Transfusion varied significantly by 
birthweight, where the highest rates occurred at the extremes. 
Gestational age had a significant inverse association with transfusion.
In a multivariable analysis of data from DNH, the only hospital 
with recorded blood loss, OH was significantly associated with 
caesa rean section (odds ratio (OR) 3.17; 95% confidence interval 
(CI) 2.16 - 4.67), positive HIV status (OR 1.64; 95% CI 1.12 - 2.39), 
gestational age ≤34 weeks (OR 2.63; 95% CI 1.24 - 5.55) and high 
birthweight (>3 770 g) (OR 3.09; 95% CI 1.35 - 7.06). In a separate 
model of transfusion, which was also limited to DNH, only OH 
(OR 62.14; 95% CI 35.90 - 107.54), and to a lesser degree increased 
parity (4+ v. 0; OR 3.31; 95% CI 1.08 - 10.16), as well as decreased 
gestational age (34 - 36 weeks v. ≥41 weeks; OR 4.32; 95% CI 1.96 - 
9.49; 37 weeks v. ≥41 weeks; OR 2.58; 95% CI 0.99 - 6.74; 38 weeks v. 
≥41 weeks; OR 3.30; 95% CI 1.62 - 6.72) were associated with receipt 
of a blood transfusion. Caesarean section patients were less likely 
to receive a transfusion after controlling for OH (OR 0.44; 95% CI 0.26 - 
0.74). Although bivariate analysis showed higher transfusion rates among 
HIV-positive patients, this association (OR 1.45; 95% CI 0.78 - 2.71) 
was not significant after controlling for OH, age category, mode of 
delivery, birthweight, parity and gestational age.
Mean antenatal haemoglobin differed significantly (p<0.001) 
between the respective hospitals (Fig. 1). Although there was not a 
significant difference in the mean pre- or post-transfusion haemoglobin 
levels across hospitals (Table 3), there was a significant mean differ-
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ence (p=0.0302) in δ-haemoglobin levels at 
DNH (1.08 g/dL), FH (1.45 g/dL) and CMH 
(1.99 g/dL). The mean number of RBC units 
per transfused patient and per delivery dif-
fered significantly by hospital; transfused 
patients received an average of 1.93 U at DNH, 
2.05 U at FH, and 2.61 U at CMH (p=0.0079). 
CMH had the highest mean number of units 
transfused per delivery (0.12), followed by 
DNH (0.07) and FH (0.03) (p<0.0001). 
Among HIV-positive women, the CD4 
count distribution did not differ between the 
hospitals (p=0.97). However, the hospitals 
differed in the proportion of women who 
received ART (p<0.0001). Of those patients 
with a CD4 <350 cells/µL (old guidelines), 
FH had the highest ART coverage (91.0% 
full ART; 6.4% PMTCT), followed by 
DNH (86.6% ART; 8.7% PMTCT) and 
CMH (79.8% ART; 15.5% PMTCT) (Table 4). 
For women with a CD4 ≥350 cells/µL, DNH 
(62.1%) had the highest ART coverage, 
followed by CMH (45.2%) and FH (10.2%; 
p<0.0001). HIV-negative women had a 
mean haemoglobin of 11.03 g/dL compared 
with 10.67 g/dL in HIV-positive women 
(p<0.001) (Fig. 2). Of the 234 women who 
were transfused, 82 (35.0%) were HIV-
positive. 
Discussion
This study describes the incidence of peri-
partum transfusion at three hospitals in the 
Eastern Cape, SA. In contrast to the four 
hospitals that participated in the earlier OH 
pilot study, the Eastern Cape hospitals are 
comparatively under-resourced, have less aca-
demic support and are located in a more rural 
setting, lending greater generalisability to the 
findings in the preceding study.[11] Estimated 
blood loss was incompletely documented at 
two of the three hospitals, precluding detailed 
analysis of OH. However, at DNH, where OH 
was routinely recorded, the OH incidence was 
4.6% (data not shown), which is higher than 
that reported in both the USA and the first 
pilot study.[11-13] Similarly, the overall transfu-
sion rate was 3.2%, exceeding that reported 
in the previous study[11] and markedly higher 
than that reported for the USA and other 
high-resource settings.[12,13] Furthermore, there 
was significant variation (1.5 - 4.6%) in the 
transfusion rates among the participating 
hospitals. While this could reflect differences 
in the patient populations, variability in clini-
cal practice (individual and/or institutional) 
cannot be excluded. Variability in practice 
might also explain differences in HIV and 
ART coverage. 
The variability in transfusion practice among 
the participating hospitals is possibly multi-
factorial. As observed in other developing 
countries,[14] this variability may be ascribed 
in part to differences in clinical practice 
by individual physician and by institution. 
Clinical transfusion practice is influenced 
by the presence of transfusion policy and/or 
Table 1. Characteristics of the study population
Characteristics All subjects, n (%) CMH, n (%) DNH, n (%) FH, n (%)
All subjects 7 234 (100) 1 641 (100) 3 191 (100) 2 402 (100) 
Age (years)
 ≤18 676 (9.3) 173 (10.5) 281 (8.8) 222 (9.2)
19 - 24 2 298 (31.8) 517 (31.5) 996 (31.2) 785 (32.7)
25 - 29 1 763 (24.4) 364 (22.2) 792 (24.8) 607 (25.3)
30 - 34 1 358 (18.8) 298 (18.2) 622 (19.5) 438 (18.2)
35 - 39 797 (11.0) 186 (11.3) 355 (11.1) 256 (10.7)
≥40 292 (4.0) 88 (5.4) 126 (3.9) 78 (3.2)
Missing 50 (0.7) 15 (0.9) 19 (0.6) 16 (0.7) 
Race
Black 6 149 (85.0) 1 623 (98.9) 2 392 (75.0) 2 134 (88.8) 
Coloured 867 (12.0) 5 (0.3) 712 (22.3) 150 (6.2) 
Asian 19 (0.3) 0 (0.0) 10 (0.3) 9 (0.4) 
White 80 (1.1) 0 (0.0) 19 (0.6) 61 (2.5) 
Missing 119 (1.6) 13 (0.8) 58 (1.8) 48 (2.0) 
Gravida (including current pregnancy)
1 2 683 (37.1) 653 (39.8) 1 117 (35.0) 913 (38.0) 
2 2 259 (31.2) 488 (29.7) 1 011 (31.7) 760 (31.6) 
3 1 392 (19.2) 306 (18.6) 625 (19.6) 461 (19.2) 
4+ 851 (11.8) 183 (11.2) 414 (13.0) 254 (10.6) 
Missing 49 (0.7) 11 (0.7) 24 (0.8) 14 (0.6) 
Para (before current delivery)
0 3 010 (41.6) 717 (43.7) 1 297 (40.6) 996 (41.5) 
1 2 297 (31.8) 487 (29.7) 1 037 (32.5) 773 (32.2) 
2 1 225 (16.9) 274 (16.7) 528 (16.5) 423 (17.6) 
3 439 (6.1) 108 (6.6) 192 (6.0) 139 (5.8) 
4+ 210 (2.9) 40 (2.4) 113 (3.5) 57 (2.4) 
Missing 53 (0.7) 15 (0.9) 24 (0.8) 14 (0.6) 
Prenatal visit
Booked 6 882 (95.1) 1 554 (94.7) 2 993 (93.8) 2 335 (97.2) 
Unbooked 266 (3.7) 72 (4.4) 143 (4.5) 51 (2.1) 
Missing 86 (1.2) 15 (0.9) 55 (1.7) 16 (0.7) 
Type of delivery
Vaginal 3 988 (55.1) 756 (46.1) 1 775 (55.6) 1 457 (60.7) 
Caesarean section 3 057 (42.3) 811 (49.4) 1 373 (43.0) 873 (36.3) 
Born before arrival 122 (1.7) 64 (3.9) 1 (0.0) 57 (2.4) 
Missing 67 (0.9) 10 (0.6) 42 (1.3) 15 (0.6) 
HIV status
Missing/unknown 110 (1.5) 25 (1.5) 35 (1.1) 50 (2.1) 
Negative 5 136 (71.0) 1 109 (67.6) 2 295 (71.9) 1 732 (72.1) 
Positive 1 988 (27.5) 507 (30.9) 861 (27.0) 620 (25.8) 
CD4 ≥350 cells/µL 885 (12.2) 241 (14.7) 369 (11.6) 275 (11.4) 
CD4 ≥200 - 349 cells/µL 463 (6.4) 129 (7.9) 197 (6.2) 137 (5.7) 
CD4 <200 cells/µL 304 (4.2) 84 (5.1) 124 (3.9) 96 (4.0) 
CD4 missing/unknown 336 (4.6) 53 (3.2) 171 (5.4) 112 (4.7) 
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guidelines, in addition to the extent to which they are mandated in 
the hospital. Current SA obstetric transfusion guidelines recommend 
antenatal transfusion for patients with symptomatic anaemia and/or 
with haemoglobin values <6 g/dL, or emergency caesarean section for 
patients with haemoglobin values <8 g/dL.[15]  Furthermore, the guidelines 
recommend maintaining a haemoglobin level >8 g/dL in patients with 
OH.[9] Importantly, the implementation of, and adherence to, transfusion 
guidelines can serve to reduce the number of transfusions without a 
concomitant increase in morbidity or mortality.[16] Differences in the 
hospital population may also contribute to the variability in blood 
utilisation. For example, a higher gravidity, parity and proportion of 
unbooked cases were noted at DNH and CMH compared with FH. 
Similar variation in blood utilisation by population has previously 
been reported in other settings.[11] The impact of blood utilisation and 
transfusion practice on patient outcomes in the obstetric setting is an 
active research focus.[16] 
Several authors have suggested that the global increase in OH is 
due to an increased incidence of uterine atony. The latter is associated 
with increased parity, high birthweight and caesarean sections,[13,17] 
Table 2. Bivariate analysis of risk factors for transfusion among 
all women (χ2 p-values) 
Risk factors
No transfusion, 
n (%)
Transfusion,
n (%) p-value
All subjects 7 000 (96.8) 234 (3.2) 
Antenatal haemoglobin (g/dL) <0.0001
Mean 10.95 10.17
Median 11.0 10.5
Hospital <0.0001
CMH 1 565 (95.4) 76 (4.6) 
DNH 3 070 (96.2) 121 (3.8) 
FH 2 365 (98.5) 37 (1.5) 
Age (weeks) 0.8855
≤18 652 (96.4) 24 (3.6) 
19 - 24 2 221 (96.6) 77 (3.4) 
25 - 29 1 712 (97.1) 51 (2.9) 
30 - 34 1 313 (96.7) 45 (3.3) 
35 - 39 773 (97.0) 24 (3.0) 
≥40 285 (97.6) 7 (2.4) 
Missing 44 (88.0) 6 (12.0) 
Race 0.2259
Black 5 955 (96.8) 194 (3.2) 
Coloured 834 (96.2) 33 (3.8) 
Asian 19 (100.0) 0 (0.0) 
White 80 (100.0) 0 (0.0) 
Missing 112 (94.1) 7 (5.9) 
Gravida 0.0789
1 2 600 (96.9) 83 (3.1) 
2 2 192 (97.0) 67 (3.0) 
3 1 354 (97.3) 38 (2.7) 
4+ 812 (95.4) 39 (4.6) 
Missing 42 (85.7) 7 (14.3) 
Para (before current delivery) 0.0493
0 2 917 (96.9) 93 (3.1) 
1 2 229 (97.0) 68 (3.0) 
2 1 190 (97.1) 35 (2.9) 
3 423 (96.4) 16 (3.6) 
4+ 196 (93.3) 14 (6.7) 
Missing 45 (84.9) 8 (15.1) 
Prenatal visit 0.0002
Booked 6 675 (97.0) 207 (3.0) 
Unbooked 247 (92.9) 19 (7.1) 
Missing 78 (90.7) 8 (9.3) 
Type of delivery 0.5197
Vaginal 3 865 (96.9) 123 (3.1) 
Caesarean section 2 961 (96.9) 96 (3.1) 
Born before arrival 116 (95.1) 6 (4.9) 
Missing 58 (86.6) 9 (13.4) 
continued …
Table 2. (continued) Bivariate analysis of risk factors for 
transfusion among all women (χ2 p-values)
Risk factors
No transfusion, 
n (%)
Transfusion,
n (%) p-value
HIV status 0.0301
Missing/unknown 98 (89.1) 12 (10.9) 
Negative 4 996 (97.3) 140 (2.7) 
Positive 1 906 (95.9) 82 (4.1) 
CD4 ≥350 cells/µL 290 (95.4) 14 (4.6) 
CD4 200 - 349 cells/µL 441 (95.2) 22 (4.8) 
CD4 <200 cells/µL 851 (96.2) 34 (3.8) 
CD4 missing/unknown 324 (96.4) 12 (3.6) 
Birthweight (g) <0.0001
<2 000 690 (93.8) 46 (6.3) 
2 001 - 2 450 698 (95.7) 31 (4.3) 
2 451 - 2 700 677 (97.0) 21 (3.0) 
2 701 - 2 900 701 (98.0) 14 (2.0) 
2 901 - 3 050 728 (98.5) 11 (1.5) 
3 051 - 3 200 750 (97.8) 17 (2.2) 
3 201 - 3 350 641 (97.1) 19 (2.9) 
3 351 - 3 510 676 (97.4) 18 (2.6) 
3 511 - 3 770 697 (97.8) 16 (2.2) 
≥3 771 675 (95.9) 29 (4.1) 
Missing 67 (84.8) 12 (15.2) 
Gestational age (weeks) <0.0001
<33 697 (93.8) 46 (6.2) 
34 - 36 1 000 (95.4) 48 (4.6) 
37 514 (97.9) 11 (2.1) 
38 1 198 (96.5) 44 (3.5) 
39 859 (97.9) 18 (2.1) 
40 2 220 (98.1) 42 (1.9) 
≥41 323 (98.5) 5 (1.5) 
Missing 189 (90.4) 20 (9.6) 
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all of which were notably also associated 
with increased rates of transfusion in our 
study. However, the association between 
increasing age, parity/gravidity and OH has 
not been consistently demonstrated,[13,17] as 
was the case in our study where increased 
transfusion rates were noted with increasing 
parity but not with increasing age. Age and 
parity are associated, which may account 
for the variable findings with regard to the 
association between increasing age, parity 
and OH noted in various publications.[13,17] Lack 
of or poor access to (or failure to access) antenatal 
care, in this instance denoted by booked v. 
unbooked cases, is a known predictor of 
poor maternal and fetal outcomes,[18] and 
is reflected in our findings by the higher 
transfusion rate among unbooked patients. 
This further underscores the importance of 
antenatal care in the prevention of obstetric 
complications. 
The study showed that HIV remains highly 
prevalent among pregnant women in SA. 
Almost a third of our patients were HIV-
positive, of whom fewer than half (45%) 
had CD4 counts >350 cells/µL and ~15% 
had CD4 counts <200 cells/µL, reflecting a 
high burden of advanced HIV disease. The 
SA guidelines for PMTCT changed during 
the course of the study, recommending full 
ART for all pregnant women, independent 
of viral load or CD4 count. Germane to 
our results, the majority of the patients 
(63%) were on full ART coverage, with a 
larger proportion of the patients on full 
ART coverage than in the preceding pilot 
study, suggesting a rapid adoption of the 
new guidelines. At DNH, multivariable 
analysis showed that caesarean section, 
positive HIV status and high birthweight 
were independently associated with OH. 
However, after controlling for OH, the odds 
of transfusion in HIV-positive patients – 
while similar to that of the preceding pilot 
study – did not attain statistical significance. 
This discrepancy could reflect the change 
to the SA guidelines; specifically, ART is 
associated with improvement of anaemia, 
which may blunt the effect of HIV on risk 
of transfusion. Moreover, the relatively small 
number of participants included in the single 
hospital analysis may have limited power to 
detect a significant HIV effect. 
In a meta-analysis of HIV and the risk of 
obstetric complications, Calvert and Rons-
mans[19] found that HIV-positive women 
had twice the odds of antepartum haemor-
rhage, but no association with postpartum 
haemorr hage. Early in the epidemic, caesa-
rean section was recommended for patients 
who were HIV-positive, potentially con-
founding an association, given increased risk 
of bleeding with operative care. The signifi-
cantly lower haemoglobin values observed 
in HIV-positive patients (also evident in 
the preceding study), reflect unaddressed 
antenatal anaemia in this population. Even 
if not sufficiently severe to warrant transfu-
sion, the low haemoglobin values, noted 
in patients at all three hospitals, confer an 
increased risk of peripartum transfusion, 
given that anaemia renders those patients 
less able to tolerate normal blood loss associ-
ated with delivery. 
Study limitations
The study had limitations. Foremost was the 
lack of routine recording of the estimated 
blood loss during delivery at two of the par-
ticipating hospitals. Second, despite selecting 
three comparatively rural and less academic 
hospitals, this study still fails to provide 
insight into the rates of OH and associated 
transfusion practice at primary level hos-
pitals. It is conceivable that OH rates may 
differ significantly in primary level hospitals, 
owing to the existing barriers to antenatal 
and high-risk obstetric care.[4,5] However, it 
would be logistically challenging to replicate 
this study at the primary care level, given the 
smaller number of deliveries and therefore 
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Fig. 1. Haemoglobin distribution by hospital.
Table 3. Red blood cell transfusions and haemoglobin values by hospital.
Characteristics CMH DNH FH p-value
Antenatal Hb (n)
Mean (median)
1 391
10.89 (10.9)
2 889
10.86 (10.8)
1 724
11.05 (11.0) <0.0001
Pre-transfusion Hb* (n)
Mean (median)
57
6.97 (6.6)
118
7.55 (7.3)
32
7.12 (6.7) 0.1036
Post-transfusion Hb* (n) 57 118 32
Mean (median) 8.96 (8.7) 8.64 (8.5) 8.57 (8.4) 0.3463
δ-Hb* (post-pre) (n)
Mean (median)
57
1.99 (2.2)
118
1.08 (1.3)
32
1.45 (1.7) 0.0302
Red blood cells (U)/transfused patient* (n)
Mean (median)
76
2.61 (2)
121
1.93 (2)
37
2.05 (2) 0.0079
Red blood cells (U) transfused/delivery (n)
Mean (median)
1 641
0.12 (0)
3 191
0.07 (0)
2 402
0.03 (0) <0.0001
Hb = haemoglobin.
*Transfused patients only.
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OH and transfusions at any one hospital. 
Because high-risk pregnancies are referred 
upward, the majority of transfusions in SA 
occur in secondary and tertiary hospitals, 
supporting our approach.
Despite the limitations, this study offers 
insight into the variability in contem porary 
obstetric transfusion practice. It has contri-
buted to the identification of antecedent 
risk factors for and the obstetric and current 
transfusion management of OH, enabling the 
implementation of systematic improvement in 
regional transfusion practice. The study also 
provides further validation of the methods and 
OHAT audit form, such that similar studies 
might be undertaken in other settings. Finally, 
while the HIV clinical data confirm enduring 
high rates of HIV in this population, they also 
suggest the successful implementation of the 
new HIV treatment guidelines.
Conclusion
This study demonstrates the high rates of 
peripartum blood transfusion in SA despite 
rates of OH that approximate those reported 
in high-income countries. Blood inventories 
in SA are strained, given the clinical demand 
(average blood reserve of 4.4 days; T Brits, 
SANBS, personal communication, 2016). 
The findings suggest that variability in trans-
fusion practice contributes to high rates 
of transfusion. Published national obstetric 
transfusion guidelines are available in SA; 
our findings suggest the need to promote 
the guidelines (e.g. using focused training) 
and review compliance.[15] Knowledge of 
blood use is imperative to the SA transfusion 
services to ensure an adequate blood supply, 
thus directly impacting a key Millennium 
Development Goal to reduce maternal mor-
tality by 75%. 
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